Marina Tadolini
- Tuberculosis (out of print)Edited by Christoph Lange and Giovanni Battista MiglioriBook | Published in 2012DOI: 10.1183/1025448x.erm5812ISBN (electronic): 978-1-84984-028-6
- TB and MDR-TB: what is new in 2012?By Marina Tadolini, Rosella Centis, Lia D'Ambrosio and Giovanni Battista MiglioriMarina Tadolini1World Health Organization Consultant, Global Fund Technical Review Panel memberRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Disease, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Disease, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Disease, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- ERS/WHO Tuberculosis Consilium: reporting of the initial 10 casesBy Lia D’Ambrosio, Marina Tadolini, Stephane Dupasquier, Simon Tiberi, Rosella Centis, Masoud Dara, Francesco Blasi and Giovanni Battista MiglioriLia D’Ambrosio1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate7Both authors contributed equallyMarina Tadolini2Section of Infectious Diseases, Dept of Medical and Surgical Sciences, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna7Both authors contributed equallyStephane Dupasquier3IT Dept, European Respiratory Society, Lausanne, SwitzerlandSimon Tiberi4Imperial College Healthcare NHS Trust, London, UKRosella Centis1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, TradateMasoud Dara5World Health Organization Regional Office for Europe, Copenhagen, DenmarkFrancesco Blasi6Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori1World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate
- Tuberculosis elimination: theory and practice in EuropeBy Lia D'Ambrosio, Masoud Dara, Marina Tadolini, Rosella Centis, Giovanni Sotgiu, Marieke J. van der Werf, Mina Gaga, Daniela Cirillo, Antonio Spanevello, Mario Raviglione, Francesco Blasi and Giovanni Battista MiglioriLia D'Ambrosio1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate11L. D’Ambrosio and M. Dara contributed equally to the studyMasoud Dara2World Health Organization, Regional Office for Europe, Copenhagen, Denmark11L. D’Ambrosio and M. Dara contributed equally to the studyMarina Tadolini3Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, BolognaRosella Centis1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, TradateGiovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU SassariMarieke J. van der Werf5European Centre for Disease Prevention and Control, Stockholm, SwedenMina Gaga67th Respiratory Medicine Dept, Athens Chest Hospital, Athens, GreeceDaniela Cirillo7Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, MilanAntonio Spanevello1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate8Università degli Studi dell'Insubria, VareseMario Raviglione9Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi10Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate
- Paediatric tuberculosis in Europe: lessons from Denmark and inclusive strategies to considerBy Ben J. Marais, Marina Tadolini, Matteo Zignol and Giovanni Battista MiglioriBen J. Marais1Marie Bashir Institute for Infectious Diseases and Biosecurity (MBI) and The Children’s Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, AustraliaMarina Tadolini2Dept of Medical and Surgical Sciences Alma Mater Studiorum, University of Bologna, BolognaMatteo Zignol3Global Tuberculosis Programme, World Health Organization, Geneva, SwitzerlandGiovanni Battista Migliori4World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Impact and management of TB childhood outbreaks in EU/EEABy Giovanni Battista Migliori, Rosella Centis, Lia D'Ambrosio, Giovanni Sotgiu, Bernadette Bourdin Trunz, Richard Godfrey, Marina Tadolini, Giorgio Besozzi, Andreas Sandgren and Marieke J. van der WerfGiovanni Battista Migliori1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyRosella Centis1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyLia D'Ambrosio1WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyGiovanni Sotgiu2Epidemiology and Medical Statistics Unit, Department of Biomedical Sciences, University of Sassari, Sassari, ItalyBernadette Bourdin Trunz3Public Health Consultant, Tuberculosis Area, Geneva, SwitzerlandRichard Godfrey4Senior TB and HIV Consultant, Dashwood, United KingdomMarina Tadolini5Global Fund Technical Review Panel Member, World Health Organization Consultant, ItalyGiorgio Besozzi6AIPO Ricerche, Milan, ItalyAndreas Sandgren7TB Programme, European Centre for Disease Prevention and Control (ECDC), Stockholm, SwedenMarieke J. van der Werf7TB Programme, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
- Tuberculosis elimination: theory and practice in EuropeBy Lia D'Ambrosio, Masoud Dara, Marina Tadolini, Rosella Centis, Giovanni Sotgiu, Marieke J. van der Werf, Mina Gaga, Daniela Cirillo, Antonio Spanevello, Mario Raviglione, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2014 in European Respiratory JournalLia D'Ambrosio1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,11L. D’Ambrosio and M. Dara contributed equally to the study,Masoud Dara2World Health Organization, Regional Office for Europe, Copenhagen, Denmark11L. D’Ambrosio and M. Dara contributed equally to the study,Marina Tadolini3Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna,Rosella Centis1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,Giovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari,Marieke J. van der Werf5European Centre for Disease Prevention and Control, Stockholm, SwedenMina Gaga67th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece,Daniela Cirillo7Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan,Antonio Spanevello1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,8Università degli Studi dell'Insubria, Varese,Mario Raviglione9Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi10Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,
- Tuberculosis elimination: theory and practice in EuropeBy Lia D'Ambrosio, Masoud Dara, Marina Tadolini, Rosella Centis, Giovanni Sotgiu, Marieke J. van der Werf, Mina Gaga, Daniela Cirillo, Antonio Spanevello, Mario Raviglione, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2014 in European Respiratory JournalLia D'Ambrosio1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,11L. D’Ambrosio and M. Dara contributed equally to the study,Masoud Dara2World Health Organization, Regional Office for Europe, Copenhagen, Denmark11L. D’Ambrosio and M. Dara contributed equally to the study,Marina Tadolini3Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna,Rosella Centis1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,Giovanni Sotgiu4Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari,Marieke J. van der Werf5European Centre for Disease Prevention and Control, Stockholm, SwedenMina Gaga67th Respiratory Medicine Dept, Athens Chest Hospital, Athens, Greece,Daniela Cirillo7Emerging Bacterial Pathogens Unit, San Raffaele Scientific Institute, Milan,Antonio Spanevello1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,8Università degli Studi dell'Insubria, Varese,Mario Raviglione9Global TB Programme, World Health Organization, Geneva, SwitzerlandFrancesco Blasi10Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori1WHO Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione Salvatore Maugeri, Care and Research Institute, Tradate,
- ERS/WHO TB consilium: reporting on initial 10 casesBy Lia D'Ambrosio, Marina Tadolini, Stephane Dupasquier, Simon Tiberi, Rosella Centis, Masoud Dara, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2013 in European Respiratory JournalLia D'Ambrosio*World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy**Equally contributedMarina Tadolini#Section of Infectious Diseases, Dept of Medical and Surgical Sciences, “Alma Mater Studiorum”, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy**Equally contributedStephane Dupasquier¶IT Dept, European Respiratory Society, Lausanne, SwitzerlandSimon Tiberi+Imperial College Healthcare NHS Trust, London, United KingdomRosella Centis*World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMasoud Dara§World Health Organization Regional Office for Europe, Copenhagen, DenmarkFrancesco BlasifDipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori*World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid useBy Susanna Esposito, Lia D’Ambrosio, Marina Tadolini, H. Simon Schaaf, Josè Caminero Luna, Ben Marais, Rosella Centis, Masoud Dara, Alberto Matteelli, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2014 in European Respiratory JournalSusanna Esposito1Pediatric Highly Intensive Care Unit, Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy10These authors contributed equally,Lia D’Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy10These authors contributed equally,Marina Tadolini3Section of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy10These authors contributed equally,H. Simon Schaaf4Desmond Tutu Tuberculosis Centre, Dept of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa,Josè Caminero Luna5Dept of Pneumology, Hospital General de Gran Canaria, Las Palmas, SpainBen Marais6Marie Bashir Institute for Infectious Diseases and Biosecurity, and Children’s Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, AustraliaRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMasoud Dara7World Health Organization Regional Office for Europe, Copenhagen, DenmarkAlberto Matteelli8Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV co-infection and TB elimination, University of Brescia, Brescia, ItalyFrancesco Blasi9Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid useBy Susanna Esposito, Lia D’Ambrosio, Marina Tadolini, H. Simon Schaaf, Josè Caminero Luna, Ben Marais, Rosella Centis, Masoud Dara, Alberto Matteelli, Francesco Blasi and Giovanni Battista MiglioriArticle | Published in 2014 in European Respiratory JournalSusanna Esposito1Pediatric Highly Intensive Care Unit, Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy10These authors contributed equally,Lia D’Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy10These authors contributed equally,Marina Tadolini3Section of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy10These authors contributed equally,H. Simon Schaaf4Desmond Tutu Tuberculosis Centre, Dept of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa,Josè Caminero Luna5Dept of Pneumology, Hospital General de Gran Canaria, Las Palmas, SpainBen Marais6Marie Bashir Institute for Infectious Diseases and Biosecurity, and Children’s Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, AustraliaRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMasoud Dara7World Health Organization Regional Office for Europe, Copenhagen, DenmarkAlberto Matteelli8Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV co-infection and TB elimination, University of Brescia, Brescia, ItalyFrancesco Blasi9Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid useBy Susanna Esposito, Lia D’Ambrosio, Marina Tadolini, H. Simon Schaaf, Josè Caminero Luna, Ben Marais, Rosella Centis, Masoud Dara, Alberto Matteelli, Francesco Blasi and Giovanni Battista MiglioriSusanna Esposito1Pediatric Highly Intensive Care Unit, Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy10These authors contributed equallyLia D’Ambrosio2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy10These authors contributed equallyMarina Tadolini3Section of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy10These authors contributed equallyH. Simon Schaaf4Desmond Tutu Tuberculosis Centre, Dept of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South AfricaJosè Caminero Luna5Dept of Pneumology, Hospital General de Gran Canaria, Las Palmas, SpainBen Marais6Marie Bashir Institute for Infectious Diseases and Biosecurity, and Children’s Hospital at Westmead, Sydney Medical School, University of Sydney, Sydney, AustraliaRosella Centis2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, ItalyMasoud Dara7World Health Organization Regional Office for Europe, Copenhagen, DenmarkAlberto Matteelli8Institute of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV co-infection and TB elimination, University of Brescia, Brescia, ItalyFrancesco Blasi9Dipartimento Fisiopatologia Medico-Chirurgica e dei Trapianti, University of Milan, IRCCS Fondazione Cà Granda, Milan, ItalyGiovanni Battista Migliori2World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Fondazione S. Maugeri, Care and Research Institute, Tradate, Italy
- Out-patient MDR-TB care in MoldovaBy Alexandru Buga, Valeriu Crudu, Liliana Domente, Gunta Dravniece, Marina Tadolini, Giovanni Battista Migliori and Davide ManisseroAlexandru Buga1TB, Institute of Phthisiopneumology "Chiril Draganiuc", Chisinau, Republic of MoldovaValeriu Crudu2Center for Health Policies and Studies, (PAS Center), Chisinau, Republic of MoldovaLiliana Domente1TB, Institute of Phthisiopneumology "Chiril Draganiuc", Chisinau, Republic of MoldovaGunta Dravniece3OSA, Otsuka SA, Geneva, SwitzerlandMarina Tadolini4Infectious Diseases Unit, Dept of Medical and Surgical, SciencesAlma Mater Studiorum, Bologna, ItalyGiovanni Battista Migliori5WHO Collaborating Centre for TB and Lung Diseases, Salvatore Maugeri Foundation Care and Research Institute, Tradate, ItalyDavide Manissero6QIAGEN, Manchester Ltd, Manchester, United Kingdom
- First independent evaluation of QuantiFERON-TB Plus performanceBy Lucia Barcellini, Emanuele Borroni, James Brown, Enrico Brunetti, Luigi Codecasa, Federica Cugnata, Paola Dal Monte, Clelia Di Serio, Delia Goletti, Giulia Lombardi, Marc Lipman, Paola M.V. Rancoita, Marina Tadolini and Daniela M. CirilloArticle | Published in 2016 in European Respiratory JournalLucia Barcellini1Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, ItalyEmanuele Borroni1Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, ItalyJames Brown2Royal Free London NHS Trust and UCL Respiratory, Division of Medicine, University College London, UKEnrico Brunetti3Dept of Infectious Diseases, San Matteo Hospital Foundation–University of Pavia, Pavia, ItalyLuigi Codecasa4Regional TB Reference Centre, Villa Marelli Institute/Niguarda Ca’ Granda Hospital, Milan, ItalyFederica Cugnata5University Centre of Statistics for Biomedical Sciences (CUSSB), Vita-Salute San Raffaele University, Milan, ItalyPaola Dal Monte6Microbiology Unit – Dept of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyClelia Di Serio5University Centre of Statistics for Biomedical Sciences (CUSSB), Vita-Salute San Raffaele University, Milan, ItalyDelia Goletti7Translational Research Unit, Epidemiology Dept, National Institute for Infectious Diseases, Rome, ItalyGiulia Lombardi6Microbiology Unit – Dept of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyMarc Lipman2Royal Free London NHS Trust and UCL Respiratory, Division of Medicine, University College London, UKPaola M.V. Rancoita5University Centre of Statistics for Biomedical Sciences (CUSSB), Vita-Salute San Raffaele University, Milan, ItalyMarina Tadolini8Infectious Diseases Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, S. Orsola-Malpighi Hospital, Bologna, ItalyDaniela M. Cirillo1Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Marie-Christine Payen, Giovanni Sotgiu, Lia D'Ambrosio, Valentina Alarcon Guizado, Jan Willem Alffenaar, Marcos Abdo Arbex, Jose A. Caminero, Rosella Centis, Saverio De Lorenzo, Mina Gaga, Gina Gualano, Aurora Jazmín Roby Arias, Anna Scardigli, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Onno W. Akkerman, Edith Alarcon Arrascue, Alena Aleska, Vera Avchinko, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workMarie-Christine Payen2Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, Belgium30These authors contributed equally to this workGiovanni Sotgiu3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy5Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workValentina Alarcon Guizado6National Tuberculosis Control Programme, Ministry of Health, Lima, PeruJan Willem Alffenaar7Dept of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsMarcos Abdo Arbex8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilJose A. Caminero10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, Spain11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceRosella Centis4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, ItalySaverio De Lorenzo12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyMina Gaga13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAurora Jazmín Roby Arias15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, FranceAlena Skrahina16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic17National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, SlovakiaGiorgia Sulis18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini19Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyOnno W. Akkerman20Dept of Pulmonary Diseases and Tuberculosis, TB Center Beatrixoord, University Medical Center Groningen, University of Groningen, Groningen, The NetherlandsEdith Alarcon Arrascue11MDR-TB Unit, Tuberculosis Division, International Union Against Tuberculosis and Lung Disease (The Union), Paris, France21International Union Against Tuberculosis and Lung Disease (The Union), Lima, PeruAlena Aleska22Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Avchinko16Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini8University Center of Araraquara, Sao Paulo, Brazil9Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López15National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries23KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst24Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli18University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri14Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou13MDR-TB Unit, Athens Chest Hospital Sotiria, National Referral Centre for Mycobacteria, Athens, GreeceAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani12AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori4WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- First independent evaluation of QuantiFERON-TB Plus performanceBy Lucia Barcellini, Emanuele Borroni, James Brown, Enrico Brunetti, Luigi Codecasa, Federica Cugnata, Paola Dal Monte, Clelia Di Serio, Delia Goletti, Giulia Lombardi, Marc Lipman, Paola M.V. Rancoita, Marina Tadolini and Daniela M. CirilloLucia Barcellini1Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, ItalyEmanuele Borroni1Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, ItalyJames Brown2Royal Free London NHS Trust and UCL Respiratory, Division of Medicine, University College London, UKEnrico Brunetti3Dept of Infectious Diseases, San Matteo Hospital Foundation–University of Pavia, Pavia, ItalyLuigi Codecasa4Regional TB Reference Centre, Villa Marelli Institute/Niguarda Ca’ Granda Hospital, Milan, ItalyFederica Cugnata5University Centre of Statistics for Biomedical Sciences (CUSSB), Vita-Salute San Raffaele University, Milan, ItalyPaola Dal Monte6Microbiology Unit – Dept of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyClelia Di Serio5University Centre of Statistics for Biomedical Sciences (CUSSB), Vita-Salute San Raffaele University, Milan, ItalyDelia Goletti7Translational Research Unit, Epidemiology Dept, National Institute for Infectious Diseases, Rome, ItalyGiulia Lombardi6Microbiology Unit – Dept of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi University Hospital, Bologna, ItalyMarc Lipman2Royal Free London NHS Trust and UCL Respiratory, Division of Medicine, University College London, UKPaola M.V. Rancoita5University Centre of Statistics for Biomedical Sciences (CUSSB), Vita-Salute San Raffaele University, Milan, ItalyMarina Tadolini8Infectious Diseases Unit, Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, S. Orsola-Malpighi Hospital, Bologna, ItalyDaniela M. Cirillo1Emerging Bacterial Pathogens Unit, Division of Immunology and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy
- Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TBBy Simon Tiberi, Giovanni Sotgiu, Lia D'Ambrosio, Rosella Centis, Marcos Abdo Arbex, Edith Alarcon Arrascue, Jan Willem Alffenaar, Jose A. Caminero, Mina Gaga, Gina Gualano, Alena Skrahina, Ivan Solovic, Giorgia Sulis, Marina Tadolini, Valentina Alarcon Guizado, Saverio De Lorenzo, Aurora Jazmín Roby Arias, Anna Scardigli, Onno W. Akkerman, Alena Aleksa, Janina Artsukevich, Vera Auchynka, Eduardo Henrique Bonini, Félix Antonio Chong Marín, Lorena Collahuazo López, Gerard de Vries, Simone Dore, Heinke Kunst, Alberto Matteelli, Charalampos Moschos, Fabrizio Palmieri, Apostolos Papavasileiou, Marie-Christine Payen, Andrea Piana, Antonio Spanevello, Dante Vargas Vasquez, Pietro Viggiani, Veronica White, Alimuddin Zumla and Giovanni Battista MiglioriArticle | Published in 2016 in European Respiratory JournalSimon Tiberi1Division of Infection, Barts Healthcare NHS Trust, London, UK30These authors contributed equally to this workGiovanni Sotgiu2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy30These authors contributed equally to this workLia D'Ambrosio3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy4Public Health Consulting Group, Lugano, Switzerland30These authors contributed equally to this workRosella Centis3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy30These authors contributed equally to this workMarcos Abdo Arbex5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilEdith Alarcon Arrascue7International Union against Tuberculosis and Lung Disease (The Union), Lima, Peru8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceJan Willem Alffenaar9University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The NetherlandsJose A. Caminero8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, France10Pneumology Dept, Hospital General de Gran Canaria “Dr. Negrin”, Las Palmas de Gran Canaria, SpainMina Gaga11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceGina Gualano12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyAlena Skrahina13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusIvan Solovic14National Institute for TB, Lung Diseases and Thoracic Surgery, Vysne Hagy, Catholic University Ruzomberok, Ruzomberok, SlovakiaGiorgia Sulis15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyMarina Tadolini16Unit of Infectious Diseases, Dept of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, ItalyValentina Alarcon Guizado17National Tuberculosis Control Programme, Ministry of Health, Lima, PeruSaverio De Lorenzo18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyAurora Jazmín Roby Arias19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorAnna Scardigli8MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease (The Union), Paris, FranceOnno W. Akkerman20University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis; TB Center Beatrixoord, Groningen, The NetherlandsAlena Aleksa21Educational Institution “Grodno State Medical University”, Grodno, BelarusJanina Artsukevich21Educational Institution “Grodno State Medical University”, Grodno, BelarusVera Auchynka13Republican Research and Practical Centre for Pulmonology and Tuberculosis, Minsk, BelarusEduardo Henrique Bonini5University Center of Araraquara, Sao Paulo, Brazil6Hospital Nestor Goulart Reis, Sao Paulo State Secretary of Health, Sao Paulo, BrazilFélix Antonio Chong Marín19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorLorena Collahuazo López19National Tuberculosis Control Programme, Pulmonology Hospital Alfredo J. Valenzuela, Guayaquil, EcuadorGerard de Vries22KNCV Tuberculosis Foundation, The Hague, The NetherlandsSimone Dore2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyHeinke Kunst23Dept of Respiratory Medicine, Queen Mary University, London, UKAlberto Matteelli15University Dept of Infectious and Tropical Diseases, WHO Collaborating Centre for TB/HIV Co-infection and for TB Elimination – University of Brescia and Brescia Spedali Civili General Hospital, Brescia, ItalyCharalampos Moschos11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceFabrizio Palmieri12Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases “L. Spallanzani”, Rome, ItalyApostolos Papavasileiou11MDR-TB Unit, Athens Chest Hospital Sotira, National Referral Centre for Mycobacteria, Athens, GreeceMarie-Christine Payen24Division of Infectious Diseases, CHU Saint-Pierre, Université Libre de Bruxelles (ULB), Brussels, BelgiumAndrea Piana2Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari – Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, ItalyAntonio Spanevello25Pneumology Unit, Fondazione Maugeri, IRCCS, Tradate, Italy26Dept of Clinical and Experimental Medicine, University of Insubria, Varese, ItalyDante Vargas Vasquez27National Hospital Hipólito Unanue, Public Health Institute, Ministry of Health, Lima, PeruPietro Viggiani18AOVV E. Morelli Hospital, Reference Hospital for MDR and HIV-TB, Sondalo, ItalyVeronica White28Dept of Respiratory Medicine, Barts Healthcare NHS Trust, London, UKAlimuddin Zumla29Division of Infection and Immunity, University College London and NIHR Biomedical Research Centre, UCL Hospitals NHS Foundation Trust, London, UKGiovanni Battista Migliori3WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy
- TuberculosisEdited by Giovanni Battista Migliori, Graham Bothamley, Raquel Duarte and Adrian RendonBook | Published in 2018DOI: 10.1183/2312508X.erm8218ISBN (electronic): 978-1-84984-100-9Giovanni Battista MiglioriGraham BothamleyRaquel Duarte
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.